Abstract:Research on pharmaceutical dry powders has been increasing worldwide, along with increased therapeutic strategies for an application through the pulmonary or the nasal routes. In vitro methodologies and tests that mimic the respiratory environment and the process of inhalation itself are, thus, essential. The literature frequently reports cell-based in vitro assays that involve testing the dry powders in suspension. This experimental setting is not adequate, as both the lung and the nasal cavity are devoid of abundant liquid. However, devices that permit powder insufflation over cells in culture are either scarce or technically complex and expensive, which is not feasible in early stages of research. In this context, this work proposes the development of a device that allows the delivery of dry powders onto cell surfaces, thus simulating inhalation more appropriately. Subsequently, a quartz crystal microbalance (QCM) was used to establish a technique enabling the determination of dry powder deposition profiles. Additionally, the determination of the viability of respiratory cells (A549) after the insufflation of a dry powder using the developed device was performed. In all, a prototype for dry powder insufflation was designed and developed, using 3D printing methods for its production. It allowed the homogenous dispersion of the insufflated powders over a petri dish and a QCM crystal, and a more detailed study on how dry powders disperse over the supports. The device, already protected by a patent, still requires further improvement, especially regarding the method for powder weighing and the efficiency of the insufflation process, which is being addressed. The impact of insufflation of air and of locust bean gum (LBG)-based microparticles revealed absence of cytotoxic effect, as cell viability roughly above 70 % was always determined.

Design and Validation of a Simple Device for Insufflation of Dry Powders in a Mice Model.

Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical Delivery in Mice

The development of a novel dry powder inhaler

Development of a dry powder insufflation device with application in in vitro cell-based assays in the context of respiratory delivery

Combining experimental and computational techniques to understand and improve dry powder inhalers

Numerical study of effects of device design on drug delivery efficiency for an active dry powder inhaler

In-vitro and Particle Image Velocimetry Studies of Dry Powder Inhalers

Investigation of Physico-Chemical Stability and Aerodynamic Properties of Novel "Nano-in-Micro" Structured Dry Powder Inhaler System

Design, development, and technical considerations for dry powder inhaler devices

Optimization and Application of an Efficient and Stable Inhalation Exposure System for Rodents

Recent developments in the computational simulation of dry powder inhalers

Designing Aerosol Therapies Based on the Integrated Evaluation of In Vitro, In Vivo, and In Silico Data

In Silico Study on the Deposition and Distribution of Particles in a Realistic Airway Model with Handilaher®

Dry powder inhaler design and particle technology in enhancing Pulmonary drug deposition: challenges and future strategies

Method for Pulmonary Administration Using Negative Pressure Generated by Inspiration in Mice

Production of Inhalable Ultra-Small Particles for Delivery of Anti-Inflammation Medicine via a Table-Top Microdevice

Cfd Simulation and Characterization of A Device for Powdered Pharmaceuticals and Biologicals Delivery

Surface Analytical Techniques in Solid-State Particle Characterization for Predicting Performance in Dry Powder Inhalers

Novel instrument to measure water uptake, dissolution and hygroscopic growth of an individual levitated aerosol particle in an environment identical to the lung (relative humidity >99.5%)

Evaluation of a novel pediatric asthma inhalation drug delivery device: a focus on patient accessibility, ease of use, dosage feedback, and future directions

Design and comprehensive characterization of dry powder inhalation aerosols of simvastatin DPPC/DPPG lung surfactant-mimic nanoparticles/microparticles for pulmonary nanomedicine